FRAXA Supporting Work Into Drug Repurposing to Treat Depression

FRAXA Supporting Work Into Drug Repurposing to Treat Depression

299706

FRAXA Supporting Work Into Drug Repurposing to Treat Depression

The FRAXA Research Foundation is supporting a project to identify available medicines that might be repurposed to treat major depressive disorder (MDD) in people with fragile X syndrome. Depression occurs frequently among people with autism spectrum disorders (ASD), of which fragile X is the most common genetic cause. However, recent research in a mouse model of fragile X suggested that standard antidepressant therapies need the FMRP protein to work. People with fragile X have little to no…

You must be logged in to read/download the full post.